Gilead Sciences to buy CGI Pharma for up to $120M – BusinessWeek

By Dr. Matthew Watson


Genetic Engineering News
Gilead Sciences to buy CGI Pharma for up to $120M
BusinessWeek
Biotechnology company Gilead Sciences Inc. said Friday it will acquire the privately held development-stage drug company CGI Pharmaceuticals for up to $120 ...
Biotech firm to phase out 150 jobsNews & Observer
Gilead Buys CGI for Up To $120MXconomy

all 81 news articles »



categoriaUncategorized commentoComments Off on Gilead Sciences to buy CGI Pharma for up to $120M – BusinessWeek | dataJune 26th, 2010

About...

This author published 5872 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024